b-cells

  1. Nightsong

    Deep Sequencing of BCR Heavy Chain Repertoires in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, 2025, Ryback et al

    Now published: see here Abstract: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a common and debilitating chronic illness of unknown aetiology. Chronic infection and autoimmune responses have been proposed as two mechanisms that potentially underlie the pathogenesis of ME/CFS...
  2. SNT Gatchaman

    Interferon subverts an AHR–JUN axis to promote CXCL13+ T cells in lupus, 2024, Law et al.

    Interferon subverts an AHR–JUN axis to promote CXCL13+ T cells in lupus Law, Calvin; Wacleche, Vanessa Sue; Cao, Ye; Pillai, Arundhati; Sowerby, John; Hancock, Brandon; Horisberger, Alice; Bracero, Sabrina; Skidanova, Viktoriya; Li, Zhihan; Adejoorin, Ifeoluwakiisi; Dillon, Eilish; Benque, Isaac...
  3. SNT Gatchaman

    Pituitary–Adrenal Axis and Peripheral Immune Cell Profile in Long COVID, 2024, Alijotas-Reig et al.

    Pituitary–Adrenal Axis and Peripheral Immune Cell Profile in Long COVID Alijotas-Reig, Jaume; Anunciacion-Llunell, Ariadna; Esteve-Valverde, Enrique; Morales-Pérez, Stephanie; Rivero-Santana, Sergio; Trapé, Jaume; González-García, Laura; Ruiz, Domingo; Marques-Soares, Joana; Miro-Mur, Francesc...
  4. SNT Gatchaman

    SARS-CoV-2 infection induces a long-lived pro-inflammatory transcriptional profile, 2023, Zhang et al.

    SARS-CoV-2 infection induces a long-lived pro-inflammatory transcriptional profile Zhang, Jia-Yuan; Whalley, Justin P.; Knight, Julian C.; Wicker, Linda S.; Todd, John A.; Ferreira, Ricardo C. The immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in...
  5. SNT Gatchaman

    Multiple Viral microRNAs Regulate Interferon Release and Signaling Early during Infection with Epstein-Barr Virus, 2021, Bouvet et al.

    Multiple Viral microRNAs Regulate Interferon Release and Signaling Early during Infection with Epstein-Barr Virus Mickaël Bouvet; Stefanie Voigt; Takanobu Tagawa; Manuel Albanese; Yen-Fu Adam Chen; Yan Chen; Devin N. Fachko; Dagmar Pich; Christine Göbel; Rebecca L. Skalsky; Wolfgang...
  6. SNT Gatchaman

    A promiscuous inflammasome sparks replication of a common tumor virus, 2020, Burton et al

    A promiscuous inflammasome sparks replication of a common tumor virus Eric M. Burton, Raphaela Goldbach-Mansky, Sumita Bhaduri-McIntosh Viruses activate inflammasomes but then subvert resulting inflammatory responses to avoid elimination. We asked whether viruses could instead use such...
  7. Dolphin

    Flow cytometric analysis of B & T-lymphocyte phenotypes in breast cancer (CFS control group), 2020, Strachan (M.D. Thesis)

    From: Dr. Marc-Alexander Fluks Source: University of Leeds Date: May 2020, online January 11, 2022 URL: https://etheses.whiterose.ac.uk/28168/ https://etheses.whiterose.ac.uk/28168/1/Final%20and%20corrected%20MD%20C.Strachan.pdf A flow cytometric analysis of B and T-lymphocyte...
  8. Sly Saint

    Patients with Persistent Polyclonal B-Cell Lymphocytosis Share the Symptomatic Criteria of Systemic Exertion Intolerance Disease, 2021, Morizot et al

    Abstract Introduction: Persistent polyclonal B-cell lymphocytosis (PPBL) is a rare and still poorly understood entity, with 90% of cases occurring in female smokers. Patients often appear tired and in pain, but the clinical symptoms remain imprecise. The main risk is the development of lymphoma...
  9. leokitten

    Sustained cellular immune dysregulation in individuals recovering from SARS-CoV-2 infection. Files et al. JCI (2020)

    https://www.jci.org/articles/view/140491 ScienceDaily News piece on paper here Of particular interest to long COVID research is they found immune dysregulation in non-hospitalized patients didn’t resolve quickly as well as activation and exhaustion markers increased during the...
  10. J

    New MS Drug Approved — Ofatumumab is first self-administered, targeted B-cell treatment for relapsing MS

    Another drug for MS, still nothing for MECFS. https://www.medpagetoday.com/neurology/multiplesclerosis/88195
  11. D

    Investigations of B cell phenotype and metabolic function in patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, Mensah, 2019 (PhD)

    Dated from April 2019, but I don't think this has been posted before. I had thought most B-cell related work would've ended with the Rituximab trial failure, but apparently not: https://discovery.ucl.ac.uk/id/eprint/10080812/20/Mensah_10080812_thesis_redacted.pdf Just starting to work my way...
  12. M

    Epstein-Barr Vaccination could reduce risks of B-cell lymphoma, study suggests

    https://lymphomanewstoday.com/2019/04/23/epstein-barr-vaccination-could-cut-risk-of-b-cell-lymphoma-study-suggests/ Chronic B-cell activation — which can happen because of infectious mononucleosis, commonly caused by the Epstein-Barr virus (EBV) — triggers an excessive proliferation of certain...
  13. Andy

    CD24 expression and B cell maturation shows a novel link with energy metabolism: potential implications for patients with ME/CFS, 2018, Mensah et al

    Currently abstract only at moment at https://www.frontiersin.org/articles/10.3389/fimmu.2018.02421/abstract
  14. Andy

    Memory B cells are reactivated in subcapsular proliferative foci of lymph nodes, 2018, Phan et al

    Open access at https://www.nature.com/articles/s41467-018-05772-7
  15. Andy

    ME Association Ramsay Research Fund invests in new study with ME/CFS Biobank to examine dysfunctional immune system and energy metabolism

    http://www.meassociation.org.uk/2018/05/me-association-ramsay-research-fund-invests-in-new-study-with-me-cfs-biobank-to-examine-dysfunctional-immune-system-and-energy-metabolism-15-may-2018/
  16. Sly Saint

    ME/CFS and the immune system. Where are we now?Geraldine (Jo) Cambridge, PhD, Dep

    RME Sverige Published on Dec 19, 2017 Geraldine (Jo) Cambridge, PhD, Dep. Medicine, University College, London on B-cell depletion with Rituximab.
Back
Top Bottom